Publication at Faculty of Medicine in Pilsen, Faculty of Science |
2015
Abstract
The development of diagnostic and therapeutic procedures in recent years have led to considerably longer survival and improved quality of life of patients with advanced-stage non-small cell lung cancer (NSCLC). Undoubtedly, one of the keys to the success is the gradual introduction of the concept of personalized cancer treatment.
The concept is based on individualization of the treatment approach based on various predictive factors that help us estimate the response to a particular treatment modality in advance. The review aims at presenting personalized cancer treatment of patients with advanced-stage NSCLC.